Vetanco presents Biotech Vac Salmonella’s innovative technology to the press

Vetanco presents Biotech Vac Salmonella’s innovative technology to the press

With the objective of introducing the new generation of vaccines against paraffinic salmonella to the Brazilian market, on September 24, Vetanco Brasil held the official launch of Biotech Vac Salmonella to the press. The meeting took place in Campinas/SP, and brought together journalists specialized in national agribusiness.

Carlos Adelino Dalle Mole

In his opening speech, the Technical/Commercial Director of Vetanco Brasil, Tiago Urbano, highlighted one of the main purposes of the laboratory. “Promote animal health and food safety. Vetanco contributes to agribusiness productivity by offering innovative products and services,” he said.

Thiago Tejkowski

Vetanco’s Technical/Commercial Biologicals manager, Carlos Adelino Dalle Mole, highlighted the multinational’s leading role. “Until now, this technology has not been used in the poultry sector. Biotech Vac Salmonella is the first subunit vaccine used in poultry farming worldwide, a new technology, different from injectable inactivated vaccines or live attenuated vaccines,” he explained.

James Urban

Vetanco Marketing Manager Thiago Tejkowski revealed that, as it is a truly differentiated tool for the control of salmonella in poultry farming, the registration of Biotech Vac Salmonella by the Ministry of Agriculture, Livestock and Supply (Mapa) took place very well. fast.

Alberto Back

Tejkowski also recalled the concept of one health. “We are talking about the protection of birds, the environment and, also, human beings, emphasizing that safety can be applied as a whole, benefiting everyone involved in animal production. A concept also known as One Health,” he said.

subunit technology

Vetanco is the first laboratory in the world to use sub-unit technology in poultry farming. Biotech Vac Salmonella was developed by Vetanco’s Director of Biotechnology, Dr. Sherry Layton, still at the University of Arkansas, one of the largest centers for poultry development and health in the world.

See also  Bolsonaro's policies cost thousands of lives every day

By using subunit technology, the vaccine is the only one that provides protection against various strains and serotypes of parathyroid salmonella, inducing mucosal and systemic immunity. It offers ample protection against serogroups B, C and D and can be used in broilers, commercial laying and heavy breeders.

Dalle Mole points out, among the benefits of this vaccine, the safe protection. “It is not a live vaccine, therefore, it does not pose any risk to the birds, and especially to the handler. Its application takes place via drinking water, providing for the welfare of the birds, in addition, it does not interfere with health monitoring and relies on the DIVA strategy, that makes it possible to differentiate the vaccinated animal from the infected one”, explains the Biologicals manager.

The Salmonella vaccine is the first on the Biotech Vac platform, and other solutions with subunit technology will soon be offered to the market.


To talk about the impact of salmonella on the poultry chain, in addition to presenting technical and scientific information, Vetanco invited the consultant and specialist in salmonella, Dr. Alberto Back. “I think we could spend maybe a week talking about salmonella, the subject is quite vast,” he said.

The expert mentioned the country’s position as the third largest producer of chicken meat in the world and one of the largest consumers. “There is also the consumption of eggs, which is quite high, 251 eggs per capita per year. And we have a risk that eggs can be a source of salmonella for humans, so this is a concern,” he stressed.

See also  Counterorder from the USA: no to aspirin to prevent strokes and heart attacks

According to Dr. Alberto, the Brazilian poultry industry is a reference in production in the world and, despite the occurrence of salmonella in birds, the quantity and frequency with which it appears, compared to the rest of the world, is much lower. “Controlling salmonella is very difficult and requires us to do procedures that are not necessary for most other diseases, and this work needs to be done as a team, at all stages of production,” said Back.

Vetanco presents Biotech Vac Salmonella’s innovative technology to the national poultry press